Dr. Ashraf Khan is an accomplished medical professional specializing in pathology. He currently serves as the Chair of Pathology at the University of Massachusetts Medical School-Baystate and Baystate Health in Springfield, MA. With extensive education and training, Dr. Khan holds an M.D. degree in Pathology from JN Medical College, Aligarh University in India, and is a Diplomate of the American Board of Pathology in Anatomic Pathology.

‍

Throughout his career, Dr. Khan has held numerous academic appointments, including Professor at the University of Massachusetts Medical School and Associate Professor at the University of Massachusetts Medical School-Baystate. He has made significant contributions to the field through his research and leadership roles, serving as the Director of Surgical Pathology, Surgical Pathology Fellowship, Pathology Residency Program, and Anatomic Pathology Quality Assurance.

‍

Dr. Khan is recognized for his expertise in endocrine pathology and has been actively involved in professional organizations such as the Endocrine Pathology Society, American Thyroid Association, and the United States and Canadian Academy of Pathology. He has received several prestigious awards, including the Distinguished Service Award from the Department of Pathology at UMass Memorial Medical Center.

‍

In addition to his academic and leadership responsibilities, Dr. Khan is committed to education and has played an integral role in teaching medical students, pathology residents, and fellows. He has also been involved in various editorial responsibilities, including serving as an Associate Editor for the Archives of Pathology and Laboratory Medicine. 

‍

Dr. Ashraf Khan continues to make significant contributions to the field of pathology through his clinical expertise, research endeavors, and commitment to education and mentorship.

‍

Dr. Anca Oniscu is an accomplished consultant pathologist with expertise in Gynaecological, Soft tissue, and Osteoarticular Pathology. As a clinical lead for Molecular Pathology services in NHS Lothian and an active member of various advisory boards and steering groups, she has played a pivotal role in advancing the field of molecular pathology in Scotland. Dr. Oniscu's dedication to education is evident through her involvement in training pathology professionals and her role as an examiner for the FRCPath in Molecular Pathology. Additionally, she has conducted impactful research - her publications encompass diverse areas of pathology research, including molecular aspects of diseases like Gorham-Stout syndrome and colorectal cancer, diagnostic biomarkers, testing strategies for Lynch syndrome, and advancements in sarcoma diagnosis.

Dr. Jason Wasserman is a distinguished pathologist and educator currently serving as a Head and Neck Pathologist at The Ottawa Hospital. He is also an Assistant Professor at the Department of Pathology and Laboratory Medicine, University of Ottawa, and a Clinician Investigator with the Cancer Therapeutics Program at the Ottawa Hospital Research Institute.  Dr. Wasserman completed his residency in Anatomical Pathology at the University of Ottawa where he served as the program's Chief Resident. Following his residency, he completed a fellowship in Head and Neck Pathology at the University of Toronto. In 2018, Dr. Wasserman founded MyPathologyReport.ca, a first-of-its-kind online pathology education resource for patients, which underscores his commitment to improving patient understanding and involvement in their health journey.

‍

Dr Christophe Rosty is a highly accomplished anatomical pathologist with a sub-speciality in GI pathology. He has a strong interest in colorectal cancer, colorectal polyps, familial predisposition to colorectal cancer, polyposis syndromes, and GI molecular pathology. With a career spanning several decades, Dr Rosty has made significant contributions to his field through his numerous publications. He has authored or co-authored 151 peer-reviewed articles, which have amassed over 12,600 citations, giving him an H-index of 57. Dr Rosty is also a co-author of the WHO classification Tumours books on Digestive System Tumours and Genetic Tumour Syndromes, which are widely regarded as authoritative references on these topics.

‍

Dr. Lauwers received his MD from the University of Paris, France. He completed a Surgical Pathology Residency at Lenox Hill Hospital, New York, NY and a Fellowship in Oncologic Pathology at Memorial Sloan-Kettering Cancer Center, where he also served as Chief Fellow. Following his Fellowship, Dr. Lauwers was in the Division of Anatomic Pathology, Department of Pathology at the University of Florida. From 2000 to 2016, Dr. Lauwers was in the Department of Pathology at Harvard Medical School and also served as Director, Gastrointestinal Pathology Service and Vice Chair, Department of Pathology at Massachusetts General Hospital.

He most recently has been a Professor in the Department of Pathology at the University of California San Francisco. He is currently adjunct Professor of Pathology at Pusan National University, School of Medicine, Pusan, Korea and Clinical Professor at the School of Pathology and Laboratory Medicine, at the University of Western Australia, in Perth. Dr. Lauwers has published over 350 peer-reviewed articles, editorials, reviews, and book chapters, and is coauthor of several textbooks, including the 5th edition of Morson and Dawson's Gastrointestinal Pathology and Advances in Surgical Pathology: Gastric Cancer.

Dr. Lauwers serves on the editorial boards of several journals, he is Deputy Editor-in-Chief of the Archives of Pathology and Laboratory Medicine, and he contributed to the WHO Classification of Tumours of the Digestive System (2010). Dr. Lauwers’ areas of clinical focus include luminal malignancies of the gut (particularly esophageal and gastric adenocarcinoma) and hepatocellular carcinoma.

Dr. Mahmut Akgul, MD, is an accomplished medical professional specializing in genitourinary pathology. He is currently a member of the faculty of pathology at Brigham and Women's Hospital.

Dr. Akgul's academic journey began at Gazi University School of Medicine in Ankara, Turkey, where he obtained his Doctor of Medicine degree. He then pursued further training and specialization in the field of pathology. He completed a residency in Anatomic and Clinical Pathology at University Hospitals Cleveland Medical Center in Cleveland, OH. Following his residency, Dr. Akgul undertook fellowships in Urologic Pathology at Indiana University Department of Pathology in Indianapolis, IN, and in Oncologic Surgical Pathology at the University of Texas MD Anderson Cancer Center in Houston, TX.

With a passion for research, Dr. Akgul has made significant contributions to the field of pathology. He has authored numerous peer-reviewed publications in esteemed journals, focusing on various aspects of genitourinary pathology, including renal cell carcinoma, oncocytic tumors, and renal epithelial neoplasms. His expertise and insights have been sought after, and he has been invited to deliver talks at prestigious institutions and conferences.

Dr. Akgul actively engages in professional activities and is a member of several renowned organizations, including the United States and Canadian Academy of Pathology, the Genitourinary Pathology Society, the International Society of Urologic Pathology, and the College of American Pathologists. He also serves as the Social Media Editor for the International Journal of Surgical Pathology and is a Curator for the Case of the Week for the Genitourinary Pathology Society.

‍

Robert M. Najarian is a highly qualified pathologist specializing in anatomic pathology with a focus on gastrointestinal, liver, and pancreatobiliary pathology. He hails from Framingham, Massachusetts, United States. Dr. Najarian completed his Fellowship in Gastrointestinal and Liver Pathology at Beth Israel Deaconess Medical Center/Harvard Medical School in 2010. With an impressive medical background, he has served as the Medical Director of the Pathology Center at University Gastroenterology in Portsmouth, Rhode Island, where he oversaw a significant annual volume of 25,000 patient cases.

Dr. Najarian's expertise lies in various areas within his specialty, including Barrett's esophagus and associated dysplasia, esophagitis, gastric cancer, celiac disease, inflammatory bowel disease, colorectal cancer, pancreatic cancer, liver neoplasia, and non-alcoholic fatty liver disease/steatohepatitis. He has made significant contributions to the field through his publications, which include research articles in prestigious journals such as the Archives of Internal Medicine, Clinical Gastroenterology and Hepatology, and the American Journal of Clinical Pathology.

Previously affiliated with Harvard Medical School, Dr. Najarian has demonstrated his commitment to academic excellence. Beyond his professional pursuits, he enjoys wine tasting, cooking, and delving into historical biographies. Dr. Najarian's passion for pathology and his extensive experience make him a respected figure in his field, dedicated to advancing knowledge and providing exceptional care to patients.

‍

Nigar Anjuman Khurram is an accomplished medical professional specializing in surgical pathology, with a particular focus on liver, transplant, and gastrointestinal pathology. Based in Pittsburgh, Pennsylvania, she brings a wealth of expertise and dedication to her field.

‍

Dr. Khurram earned her MD qualification and subsequently delved into the intricacies of surgical pathology. Her dedication to understanding the complexities of liver diseases, including tumors and medical conditions, led her to specialize in liver transplant pathology. Her deep-seated interest in this field has propelled her to contribute significantly to the medical community's understanding of liver health.

‍

Dr. Khurram's commitment to advancing medical knowledge is reflected in her extensive publication record. Her research covers a broad spectrum of topics within her field, from the molecular analysis of lung cancer to the study of liver allograft health. She has also delved into the intricate interplay between COVID-19 and the human body, investigating the effects of the virus on different organ systems.

‍

As an esteemed member of the academic community, Dr. Khurram is affiliated with the University of Pittsburgh. Her passion for teaching and research is evident in her engagement with medical students and colleagues alike.

‍

Beyond her professional achievements, Dr. Khurram leads a vibrant life outside of medicine. Her interests span from 3D animation design to gardening and cooking, showcasing her multifaceted personality.

‍

Dr Abi Daoud completed her Fellowship in dermatopathology at the University of Toronto and University Health Network, Toronto, Ontario, Canada.

His clinical practice covers medical, transplant and oncologic diseases of the liver, with more than 15 years' experience as a hepatobiliary pathology sub-specialist. His primary research interest is in transplant and tumor immunology. During his career he has combined an active clinical service with research and teaching as well as participating locally, nationally, and internationally as a key resource in medical, transplantation and oncologic liver diseases.

Dr Adeyi's research has focused on the interplay between the immune system on the one hand and allogeneic, tumor and viral antigens on the other. In collaboration he has used murine and pig models to study varying aspects of alloimmunity, infections, and tumorigenesis in modified immunologic backgrounds, with a view to understanding how best to utilize the innate and specific immune systems in achieving better outcomes in solid organ transplantation and malignancies, as well as viral infections and organ preservation injury.

Dr. Ahmed then completed a residency in anatomic and clinical pathology at Loyola University Medical Center in Chicago, followed by hematopathology fellowship at Yale and dermatopathology fellowship at the University of Arkansas for Medical Sciences. 

Following training, Dr. Ahmed started his career as an assistant professor at Rush University Medical Center in Chicago, gaining independent sign-out experience in inpatient, outpatient and consult cases in dermatopathology and hematopathology. Dr. Ahmed currently serves as director of the dermatopathology section at the Illinois Dermatology Institute while holding an adjunct appointment in the department of pathology and laboratory medicine at Loyola Stritch School of Medicine where he continues to be involved in education and research activities. 

In addition to his passion for routine dermatopathology, his background in hematopathology gives him additional diagnostic expertise in skin lymphomas. Dr. Ahmed is well-published, has won several national awards, and sits on multiple committees of the College of American Pathologists and the American Society of Dermatopathology.

Holding qualifications including MUDr and FRCPath, Dr. Al-Qsous's research delves into melanocytic lesions, skin lymphomas, and haematological malignancies. Notable publications include studies on diagnostic pitfalls in leukaemia, COVID-19 immunopathology, and desmoplastic stromal changes in tumours. His expertise and dedication to advancing pathology contribute significantly to medical knowledge and patient care. Dr. Al-Qsous's comprehensive understanding of complex diseases and his commitment to excellence in diagnosis and research make him a respected figure in the field, admired for his insightful contributions to histopathology.

Dr. Allo's postgraduate training includes a residency in Anatomical Pathology at the University of Toronto and a Gynecologic Pathology fellowship at the University of Michigan. These experiences have provided him with extensive knowledge and hands-on training in diagnosing and analyzing various diseases and conditions.

‍

Currently, Dr. Allo serves as the Associate Program Director of Anatomical Pathology and a Senior Staff Pathologist at Henry Ford Hospital in Detroit, Michigan. He plays a crucial role in overseeing and guiding the training of pathology residents while actively contributing to patient care through accurate and timely diagnoses.

‍

Dr. Allo is a board-certified Fellow of the American Board of Pathology and the Royal College of Physicians and Surgeons of Canada, indicating his commitment to maintaining the highest standards of professional excellence. He is a member of several prestigious professional societies, including the International Society of Gynecologic Pathology, the International Society of Gynecologic Oncology, and the United States and Canada Academy of Pathology.

‍

Throughout his career, Dr. Allo has received numerous honors and awards, including the Hour Detroit Best Doctor title in 2021 and the F. Stephen Vogel Award from the United States and Canada Academy of Pathology. He has also secured research grants and contracts, allowing him to pursue important studies in the field of pathology.

‍

Dr. Allo's contributions extend beyond clinical practice and research. He is actively involved in teaching and mentoring aspiring pathologists and has published several articles in esteemed scientific journals. His dedication to advancing the field of pathology and improving patient outcomes is evident in his continuous pursuit of knowledge and his involvement in professional societies.

‍

With his extensive expertise, passion for pathology, and commitment to excellence, Dr. Allo continues to make significant contributions to the medical community and the patients he serves.

‍

Dr. Ansari has numerous publications in the field of Histopathology and Dermatopathology, including the largest series of Eccrine Porocarcinoma published in the American Journal of Surgical Pathology. He received his training at the John Radcliffe Hospital, Oxford; and St. Thomas’ Hospital / St.John’s Institute of dermatology, London. Dr Ansari is an International Speaker, and has written several journal articles and book chapters.

With a dual specialization in General Pathology and Anatomical Pathology, Dr. Arredondo has a particular focus on Pediatric Pathology. His expertise encompasses a range of pediatric tumors, including leukemia/lymphomas, soft tissue, liver, renal, and neuroendocrine tumors.

Additionally, he has a profound interest in pediatric gastrointestinal diseases and perinatal pathology, which includes the study of placentas, products of conception, malformations, and autopsies.

Dr. Arredondo is also skilled in electron microscopy, applying this technique to tumors, gastrointestinal diseases, metabolic conditions, cilia, and storage diseases. His commitment to advancing pediatric pathology through both clinical practice and academic contributions underscores his dedication to improving healthcare outcomes for the youngest patients.

Dr. Amal Asar is a Locum Consultant Histopathologist at Salford Royal NHS Trust, where she she specialises in breast and GI pathology. Dr. Asar has a particular interest in digital Pathology and AI in Pathology, and in immunotherapy prospects in cancer treatment. She has been involved in teaching and research throughout her career, having worked as a Teaching Assistant of Pathology and Assistant Researcher of Pathology in a number of universities and medical centres in Egypt. Additionally, she has authored a research paper titled "Immunohistochemical study of the expression of OCT-4 in bladder urothelial carcinoma and its variants," which was published in the Kasr El Ainy Medical Journal. Dr. Asar is a member of several professional bodies, including the Royal College of Pathologists and the International Society of Breast Pathology. She is also an associate member of the Academy of Medical Educators and a regular member of the United States and Canadian Academy of Pathology.

Dr. Aslam received his MBBS in Pakistan 1995, and was interested in pathology from the beginning of his medical career.  After gaining experience in various pathology disciplines in Pakistan for 5 years, Dr. Aslam entered into higher specialist training to achieve his FRCPATH certification in UK. He joined East Lancashire NHS as a consultant in 2006, where he was actively involved in various management roles. Dr. Aslam joined North Wales NHS 2015 to lead the surgical pathology and digital pathology implementation project. Currently Dr. Aslam is working as a clinical director for North Wales diagnostic and specialist clinical services including radiology, pathology, audiology, medical physics and neurophysiology.

Dr. Aslam’s key interests include service improvement, teaching, innovation and management and teaching. Among clinical activities he had special interest in head and neck, skin, urology, and upper and lower GI pathology including reporting ESDs. He also performs autopsies for the HM Coroners and consent autopsies for hospital.  He is also interested in non-gynaecological cytology and routinely report them.

She is based in Canada and has multiple publications focused in the areas of Stem Cells, Familial Breast Cancer, Biomarkers and Radiation Therapy.

Dr. Bashat's interests lie in fine needle aspiration and rapid on-site evaluation, showcasing her commitment to precise and efficient diagnostic techniques. In addition to her clinical practice, Dr. Bashat is actively involved in education and training, reflecting her dedication to fostering the next generation of pathologists. Her contributions to the field are evident through her publications, which contribute to advancing knowledge and understanding in pathology.

Affiliated with the University of Aberdeen, Dr. Ghada Bashat plays a pivotal role in both clinical practice and academic research, shaping the future of pathology.

In 1995, he came to the United Kingdom to undertake a Diploma in Clinical Dermatology organised by the UMDS (King’s College London now) and subsequently became a research fellow at St John’s Institute of Dermatology, London. Dr Ben-Gashir has practiced clinical dermatology at St John's Institute of Dermatology, London, UK. He has been awarded a PhD from the University of London for his work on Childhood atopic dermatitis.

He has presented his work at national and international meetings and he won the prize for best presentation and best paper at the British Society for Paediatric Dermatology during the 81st annual meeting of the British Association of Dermatologists, Cardiff, July 2001. He has published a number of original papers and has reviewed articles in both national and international journals.

After completing his training in dermatology, he joined the UK training program in histopathology and became a fellow of the Royal College of Pathologists (FRCPath), London in 2012 and awarded Certificate of Completion of Training (CCT) in Histopathology 2012. He started working as an acting-up consultant at Guy’s and St Thomas’ Hospitals including the dermatopathology department at the St John’s Institute of Dermatology and consultant pathologist in the UK before getting a permanent consultant Pathologist job in Qatar 2015 at the Hamad Medical Corporation, the sole health care provider in the state of Qatar. In January 2021, he moved back to the UK where started working in Bedford Hospital.

His areas of interest include; carcinogenesis, EMT and mechanisms of invasion and metastasis. Along with morphological manifestations of clinically actionable mutations. Dr. Bracey has numerous publications in peer-reviewed literature.

Dr Bryson is a specialist gynaecological pathologist and core member of the West of Scotland Gynaecological Cancer MDT. His non-clinical interests include efficient systems, laboratory modernisation and workload measurement and digital pathology. He is the Scottish Pathology Network Lead for Digital Pathology.

In addition, he is an Honorary Clinical Associate Professor at the University of Glasgow and Honorary Senior Lecturer at University of St Andrews, contributing to the Innovate UK funded iCAIRD programme.

Most recently he has been the Program Medical Director and Pathologist in Chief/Professor of Pathology at University Health Network and University of Toronto, Head of Translational Pathology at the University of Oxford, and Head of Histopathology at Brighton and Sussex University Hospitals Trust. Prof Chetty’s area of interest in his specialty is mechanisms of tumourigenesis.

Since beginning her clinical practice in 2013, she has specialised in Surgical Pathology with sub-specialties in Head & Neck and Endocrine Thyroid & Parathyroid Pathology. Renowned for her expertise in neoplasms of the thyroid, salivary glands, and head & neck mucosal sites, Dr. Cipriani has contributed significantly to the field through numerous noteworthy publications. These have included research on vocal cord paralysis, glomus tumors, and a report on pleural metastasis from parotid secretory carcinoma to name a few. Her extensive research and dedicated clinical practice have established her as a leading expert and invaluable resource in her field.

With a distinguished academic background including a PhD, MD, DipMedEd, and RCPath qualification, she is recognized for her expertise in Histopathology, particularly in the sub-specialties of Gastrointestinal pathology.

Throughout her career, Dr. Collantes-Bellido has developed a profound interest and expertise in inflammatory bowel disease (IBD), pancreatic cancer, and coeliac disease. Her dedication to these areas has led to significant contributions to the field, with research published in prestigious journals such as Nature Medicine.

Dr. Collantes-Bellido is widely respected for her unwavering commitment to patient care and the pursuit of medical excellence. With her extensive experience and expertise, combined with her significant contributions to scientific research, she stands as a distinguished figure in the field of GI pathology, dedicated to improving patient outcomes and advancing medical knowledge.

He previously was Head and Chair of Pathology at the University of Witwatersrand, Johannesburg, South Africa and Director of Anatomic Pathology at the University of Vermont, USA. 

He obtained his PhD at Oxford University: studying the role offHPV in uterine cervical carcinomas. 

Dr Cooper conceived, planned and activated the Botswana Rotation/Elective through the Botswana-UPenn Partnership. This program was initiated in October 2016 whereby Dr Cooper spends two months a year (October and April) at the University of Botswana teaching and signing out cases with the residents. His clinical experience comprises Jan 1982-Dec 1989/Dec 1992-Mar 1999: Routine Post Mortem and Surgical Pathology including use of Electron Microscopy, Immunofluorescence, Frozen Sections and Immunohistochemistry. May 1999-present: Routine general Surgical pathology sign out. Dr Cooper over 290 published manuscripts and over 100 published abstracts.

His current areas of sub-speciality interest are Head and Neck, and Soft tissue pathology.

He is based in Derby, UK and has multiple peer review articles published in histopathology, forensic medicine, medical law and bioethics. Dr Dada has also held the Chair of Forensic Pathology at the Nelson R Mandela School of Medicine, University of KwaZulua Natal, South Africa.

He is based in Pittsburgh, Pennsylvania / United States. He completed his Bone and Soft Tissue Pathology Fellowship in the University of Pittsburgh Medical Center, Pittsburgh. Dr. Dantey has several publications in peer-reviewed literature.

His areas of interest include; Dermatopathology, GI, Breast, Gyn and Uropathology. Dr Dasgupta also has a keen interest in the application of Artificial Intelligence and Deep Learning to Pathology, with numerous recent publications.

His areas of interest are Pancreas, Liver and tubular gut. Prof. Deshpande’s research has focused on surgical pathology in the areas of gastrointestinal and connective tissue diseases. His contributions to the field of IgG4-related disease have been instrumental in establishing diagnostic criteria, as well as pioneering new treatments for this disease.

Prof. Deshpande has published over 100 peer-reviewed articles, editorials, reviews and book chapters and has been an invited speaker at major national and international pathology meetings. Prof. Deshpande serves on the editorial boards of the Archives of Pathology and Laboratory Medicine, and Diagnostic Histopathology, and is Editor in Chief of the Journal of Clinical Pathology.

His areas of interest are Lung Cancer Clinical Trials, Lung Imaging and Pathological Correlation and Mesothelioma. Dr Dick serves as an honorary clinical lecturer for University of Glasgow with numerous publications focused on lung pathology.

He has multiple peer reviewed publications and is based in Toronto, Canada.

With over 100 publications, Mona El-Bahrawy's work focuses on uncovering diagnostic biomarkers and potential treatments for gynaecological tumours. Recent discoveries from her lab include the identification of molecular subtypes of serous borderline ovarian tumours. She is determined to identify predictive biomarkers and therapeutic targets to address unmet clinical needs in the field. As a significant contributor to Imperial College London, her work continues to make considerable impacts on Gynaecologic pathology.

He serves as the Medical Director and Pathologist in Chief at MacKenzie Health, Toronto, Canada, one of the first laboratories to implement whole slide imaging for primary reporting. He was formerly Director of Computational Pathology at University Health Network (UHN). He is the Chair of the College of American Pathologists Digital Pathology committee and has authored numerous publication on guidelines for implementation, quality and practice of digital pathology for primary diagnostics. As such he is a leader and opinion shaper in this area. Additionally, Dr Evans has written numerous papers in GU pathology and is internationally renowned in this sub-speciality.

He holds a Medical Doctorate from the University of Rochester School of Medicine and Dentistry, where he also completed his residency in Anatomic and Clinical Pathology, serving as Chief Resident from 2020 to 2021. He further pursued a fellowship in Gastrointestinal Pathology at the University of Utah.

With a rich academic background in Biomedical Engineering, Dr. Farhat earned his Ph.D. from the University of Rochester, focusing on the role of matrix turnover proteins in models of flexor tendon healing. His extensive research experience spans various aspects of pathology, including tumor analysis, histologic grading, immunostaining, and the correlation of microscopic findings with surgical pathology reports.

As a Staff Pathologist at Ascension St. John Hospital in Detroit, MI, Dr. Farhat managed general sign-out responsibilities in a busy academic hospital-based practice, specializing in gastrointestinal specimens. He actively participated in teaching sessions with pathology residents and contributed significantly to case sign-out sessions.

Dr. Farhat has been actively engaged in multiple research projects, including work on tissue bank quality assurance, examining esophageal biopsies, evaluating pancreatic neuroendocrine tumors/carcinomas, and cytopathology research. He has presented his findings at various professional society meetings, including the United States and Canadian Academy of Pathology and the Orthopaedic Research Society.

His commitment to education and leadership is evident through his roles as Chief Resident, where he organized resident surgical pathology unknown conferences, led teaching sessions for pathology residents, and served as a liaison between residents, department leadership, and laboratory personnel.

Despite being in private practice, Dr. Farhat has demonstrated a deep commitment to academia, with multiple peer-reviewed publications in prestigious journals and an extensive portfolio of presentations at national and local conferences. His expertise and contributions have been acknowledged through numerous awards and honors, including the Myron Schuster Residents Award and NIH pre-doctoral grant recipient status.

Dr. Farhat is an active member of several professional societies related to pathology, including the Pancreatobiliary Pathology Society, Hans Popper Hepatopathology Society, and the United States and Canadian Academy of Pathology, among others.

Dr Cyril Fisher is a renowned specialist soft tissue tumour pathologist with a distinguished career in academia and pathology. He was born in the UK and trained at Oxford University and University College London. After completing his medical degree, he pursued a career in diagnostic histopathology, with a sub-specialty in soft tissue tumours.

‍

Dr Fisher has made significant contributions to the field of pathology through his research and publications. He has authored or co-authored over 650 peer-reviewed papers and three textbooks, including "Biopsy Interpretation of Soft Tissue Tumors" and "Atlas of Soft Tissue Tumor Pathology." His research interests include morphology, immunohistochemistry, molecular pathology, and clinico-pathological correlations.

‍

Dr Fisher is an Emeritus Professor of Tumour Pathology at the Institute of Cancer Research, University of London, UK, and a Consultant Histopathologist at University Hospitals Birmingham, UK. He has also served on various editorial boards and has been involved in numerous international committees, including the International Agency for Research on Cancer (IARC) Working Party.

‍

Dr Fisher is a respected authority in his field and has received several prestigious awards and honors for his contributions to pathology, including the President's Medal of the British Division of the International Academy of Pathology.  He is a Past-President of the International Society of Bone and Soft Tissue Pathology.  He is a fellow of the Royal College of Pathologists and has been recognized as one of the most cited researchers in pathology. Dr Fisher continues to be actively involved in pathology research and education, and his work has had a significant impact on the field.

‍

‍

His research interests include the pathogenesis of Primary Sclerosing Cholangitis, and the molecular analysis of tissue. He has over 200 publications and a H-index of 49.

Dr. Trevor Flood is an accomplished Diagnostic and Molecular Pathologist specializing in Genitourinary Pathology, boasting extensive academic affiliations and a wealth of experience in the field. He earned his Doctorate in Medicine from The University of Ottawa's Faculty of Medicine and completed his residency in Anatomical Pathology at the University of Ottawa - The Ottawa Hospital.

Further advancing his expertise, Dr. Flood pursued a fellowship in Genitourinary Pathology at Harvard Medical School's Brigham and Women’s Hospital. He returned to Ottawa to join The Ottawa Hospital as a pathologist, concurrently holding the position of Associate Professor at The University of Ottawa and clinician scientist at The Ottawa Hospital Research Institute.

With over a decade of experience, Dr. Flood's research focuses on prostate, kidney, and penile cancer, integrating multidisciplinary approaches to genitourinary issues in collaboration with Diagnostic Radiology and Surgical Oncology. He has contributed significantly to the field, authoring over 90 peer-reviewed publications and being a sought-after speaker at various national and international conferences.

Dr. Flood has actively participated in clinical trials and has served on several international and provincial advisory committees. He has been involved in establishing international standards in pathology and has made substantial contributions to updating and refining classification systems in the field.

Key publications authored by Dr. Flood include seminal works on the prognostic impact of cribriform morphology in prostatic adenocarcinoma, the utility of multiparametric renal CT algorithms for diagnosing clear cell renal cell carcinoma, and exploring the molecular pathogenesis of penile squamous cell carcinoma. His expertise also extends to the evaluation of prostate cancer using advanced imaging techniques and histopathological correlations.

As a testament to his academic contributions, Dr. Flood has served on numerous editorial boards for prestigious journals and has been involved in various local committees and educational programs, significantly impacting the training of future pathologists.

His professional memberships include Fellowships at the Royal College of Physicians and Surgeons of Canada and the College of Physicians and Surgeons of Ontario. Dr. Flood is an esteemed member of the United States and Canadian Academy of Pathology (USCAP) and the International Society of Urologic Pathology (ISUP), among others.

Specializing in Histopathology, his sub-specialties include neoplastic skin and gastrointestinal pathology, with a particular focus on colorectal carcinoma.

Dr. Foong's dedication to his specialty is evident through his contributions to the field, including publications that advance knowledge and understanding in pathology.

With extensive qualifications and expertise, Dr. Keen Shawn Foong plays a significant role in both clinical practice and academic research, shaping the future of pathology in the United Kingdom.

Dr. Gomes is affiliated with The Ottawa Hospital and the University of Ottawa, where he holds a distinguished teaching position within the Faculty of Medicine. With over a decade of university appointments, he has served as a Full Professor since 2023, an Associate Professor from 2013 to 2023, and previously as an Assistant Professor from 2008 to 2013.

His clinical expertise encompasses critical areas within his specialty, including lung cancer, interstitial lung diseases, mesothelioma, thymic tumors, and upper gastrointestinal pathology. Dr. Gomes has actively contributed to the academic community through 59 key publications and significant involvement in medical education through workshops and lectures in national and international conferences.

As a leader in his field, Dr. Gomes has played pivotal roles in shaping international standards in pathology. He has been a member of various boards and committees, serving as a clinician educator at the Royal College of Physicians and Surgeons of Canada and the Planning Committee for several international conferences on residency education. He was also the Chair of the Canadian Association of Pathologists Annual Meeting from 2016 to 2018.

Dr. Gomes has received numerous honors and awards for his outstanding contributions to pathology, including several leadership, education and research awards such as the Leadership in Pathology award by the Canadian Association of Pathologists, the Robert Maudsley Fellowship of the Royal College of Physicians and Surgeons of Canada, and the Clinical Teaching Award by the Professional Association of Residents of Ontario.

His involvement in multidisciplinary initiatives is noteworthy, having led the Ottawa Hospital Thoracic Oncology Summit for more than a decade, and currently leading the development of Molecular Tumour Boards. He participated in the Regional diagnostic process redesign at The Ottawa Hospital Cancer Program, and is a strong advocate for pathologists to become leaders of evolving healthcare teams. Dr. Gomes has been actively engaged in the establishment of multidisciplinary clinical guidelines and standards for the province of Ontario, notably in the field of Thoracic Oncology, through his collaborations with Cancer Care Ontario. 

In addition to his academic and clinical achievements, Dr. Gomes is multilingual, fluent in English, French, Portuguese, and Spanish. Beyond his professional pursuits, he enjoys engaging in hobbies like triathlon, water polo, snowboarding, sailing and exploring food and wine.

His areas of interest include Breast Biomarkers and Sarcoma. As an Assistant Professor at the University of Ottawa, he combines academic involvement with extensive clinical experience. With over a decade of contributions to pathology, Dr. Gravel has notably researched and published on various topics in renowned journals such as Skeletal Radiology, Head and Neck Pathology, and the Annals of Surgical Oncology. His work spans publications on topics ranging from neoadjuvant chemotherapy in breast cancer to novel diagnostic techniques for various pathologies. Dr. Gravel's commitment to academia, combined with an impressive clinical background, positions him as a pivotal figure in advancing the understanding and diagnosis of complex pathological conditions.

Following pathology residency, Dr. Gross pursued specialized fellowship training in bone and soft tissue at the University of Washington in Seattle, WA followed by additional fellowship in surgical pathology at the Mayo Clinic in Rochester, MN. In 2020, Dr. Gross became an assistant professor in the Department of Pathology at Johns Hopkins (2020) where he brings expertise in bone and soft tissue and surgical pathology.

Dr. Gross has an academic interest in bone and soft tissue tumors and has authored over a dozen articles and chapters and given national and international presentations on sarcoma pathology.

Her areas of interest include Molecular pathology and teaching. Dr Hawari is also a cytopathologist with subspecialty expertise in cervical and respiratory cytology.

Graduating from the University of Miami's Honors Program in Medicine, she holds board certifications in Anatomic Pathology and Molecular Genetic Pathology, complemented by fellowship training in Gastrointestinal Pathology and Molecular Genetic Pathology from prestigious institutions.

With a primary focus on oncologic pathology, Dr. Hechtman has left an indelible mark on her specialty, having authored over 100 peer-reviewed manuscripts in distinguished journals. Her extensive academic journey includes a significant role at Memorial Sloan Kettering Cancer Center in New York City, where she served as an Assistant and later an Associate Member for seven years. Currently, she continues to excel as an Oncologic and Molecular Pathologist at Caris Life Sciences.

Dr. Hechtman's dedication to advancing the field of Pathology and her unwavering commitment to improving patient care make her a respected and influential figure in the medical community.

Within his department he is the subspecialist lead for Gastrointestinal Pathology and Cytopathology, he also practices in the fields of Pulmonary Pathology, Malignancy of Unknown Origin and Neuroendocrine Tumour Pathology. As well as being a Fellow of the Royal College of Pathologists, where he is the National Advisor for Ukrainian Pathology, he is also a Fellow of the Institute of Biomedical Scientists.

Tom's educational journey includes a Doctor of Medicine degree from Wayne State University and a Bachelor of Science in Neuroscience from the University of Michigan. He completed his residency in Anatomic & Clinical Pathology and a Cytopathology Fellowship at the Hospital of the University of Pennsylvania. He is board certified in both Cytopathology and Anatomic and Clinical Pathology by the American Board of Pathology.

In addition to his clinical responsibilities, Tom is actively involved in teaching and mentoring aspiring medical professionals. He serves as faculty at the Perelman School of Medicine at the University of Pennsylvania, where he contributes to various small group sessions and instructs in areas such as renal, endocrine, cardiovascular, and gastrointestinal pathology.

Tom has also contributed to the advancement of the field through lectures, seminars, and presentations. He has delivered presentations on a range of topics, including breast pathology, molecular testing in breast cancer, and various case studies. His commitment to quality improvement and patient safety is evident through his involvement in projects focused on molecular pathology, clinical chemistry, microbiology, and anatomical pathology.

Outside of his professional pursuits, Tom has a passion for music. He has been actively involved in a cappella singing, being a member of the Michigan G-Men and The Ultrasounds during his undergraduate and medical school years. His beatboxing skills have also earned him recognition, including winning awards for outstanding vocal percussion. Tom continues to pursue his musical interests and has even led workshops on beatboxing.

She is based in Canada and has several publications. She carried out her traineeship at both the Mayo Clinic and NYU Medical Center. Dr Joseph is a Professor in the Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.

‍

Dr. Jason Karamchandani, an Associate Professor in the Department of Pathology, Neurology and Neuroscience at McGill University is a practicing neuropathologist at The Montreal Neurological Institute and Hospital. A graduate of Harvard University with an honours degree in biochemistry, he proceeded to complete medical school training at Stanford University, where he was class valedictorian. He remained at Stanford for residency and fellowship training in anatomic pathology and neuropathology (he is board certified in both). Dr. Karamchandani's research focuses on utilizing bio-informatic data to identify biomarkers for brain tumors as well neuromuscular disorders and rare neurological diseases. His significant roles include an 8-year tenure as director of immunohistochemistry and special stains at the MUHC, and program director for the McGill Anatomic Pathology residency program (2015-2020). He has published over 80 journal articles in peer-reviewed publications and five book chapters focused on neuropathology. He has been a member of the Royal College specialty committee for diagnostic and molecular pathology since 2015, and has been a member of the board of directors for the Canadian Association of Pathology since 2015.

Trained in Iran, the UK, and Canada, he is a Fellow of both the Royal College of Pathologists in the UK and the Royal College of Physicians and Surgeons in Canada. Dr. Kazerouni is currently a Consultant Pathologist at Juravinski Hospital in Hamilton and has previously served as Chief of Anatomical Pathology at Western Health in Newfoundland. Recognised for his commitment to education, he has received awards including the John Fernandes Teaching Award from McMaster University and has taught undergraduate medical students at Oxford University Medical School. Dr. Kazerouni is also a noted author, contributing to peer-reviewed publications on subjects such as lung adenomas and neuroendocrine carcinoma.

With a robust educational background encompassing an MB.,ChB., along with a Dip Ophth(RCS), MRCP(UK), and FRCPath Diploma in Dermatopathology (ICDP UEMS), Dr. Keen's expertise lies in the intricate realms of dermatology and pathology. His passion converges on the exploration of inflammatory and neoplastic skin diseases, where he has made significant contributions through his extensive publications, particularly in dermatopathology and studies concerning foreign and crystalline materials in tissues. Prior to his current endeavours, Dr. Keen served as an Honorary Lecturer/Senior Lecturer in the Peninsular Medical School and at Guy’s Hospital in the GKT School of Medical Education, where he imparted his knowledge and nurtured future generations of medical professionals.

She moved to Massachusetts General Hospital and Harvard Medical School for post-graduate training, including residency in Anatomic Pathology and fellowships in Bone & Soft Tissue and Head & Neck Surgical Pathology as well as Cytopathology. After completing her training, she practiced subspecialized academic pathology, with a focus on sarcoma and head and neck pathology, at the University of Miami Miller School of Medicine before returning to practice at Dartmouth, where she currently serves as subspeciatly director for the Bone & Soft Tissue and Head & Neck Pathology Divisions.

She has been an invited speaker at national and international pathology meetings and been awarded multiple teaching awards. Dr. Kerr has published over 75 peer-reviewed articles and contributed to several textbooks, including the Bone chapter in Histology for Pathologists (Mills SE, 5th edition) and to the 5th editions of the WHO "blue books," Tumours of Endocrine Organs and Head and Neck Tumours. She serves on the editorial board of Head and Neck Pathology and is an Associate Editor for International Journal of Surgical Pathology.

His areas of interest include; Salivary gland pathology, Digital Pathology and Artificial Intelligence. Dr Khurram’s main interests is the application of Artificial Intelligence and Deep Learning to Pathology with numerous recent publications. At present, Dr Khurram is involved in a number of national and international collaborative projects exploring ‘novel digital biomarkers’ in cancers and pre-cancers.

Currently positioned at the prestigious Queen Elizabeth University Hospital (QEUH) in Glasgow, he specializes in Gastrointestinal Pathology, particularly luminal, pancreatico-biliary, and medical liver pathology, handling a substantial portion of the hospital's extensive workload. Driven by his pivotal role as Clinical Lead from 2013 to 2016, overseeing the largest gastro-intestinal subspecialty team at the QUEH Pathology department, he contributed significantly to research, audits, and scientific reviews. Beyond his professional commitments, Dr. Konanahalli is deeply engaged in teaching and training biomedical scientists, histopathology trainees, and medical students, cementing his legacy as a multifaceted medical professional.

She serves as faculty at the David Geffen School of Medicine, University of California, Los Angeles. Dr. Laklouk’s clinical interests include salivary gland tumors, thyroid carcinomas, and the molecular and immune microenvironment in head and neck tumors. Board-certified in Anatomic and Clinical Pathology by the American Board of Pathology.

Dr. Laklouk has co-authored numerous peer-reviewed publications and has presented her research at many international conferences. Her work focuses on advancing understanding of oncologic pathology, particularly in renal cell carcinoma and thyroid cancer. Outside her professional commitments, she enjoys reading, travel, hiking, and photography.

Dr Qassid completed his histopathology training in London in 2016. Prior to his pathology training, He trained in medicine and surgery with South Wales health boards. Dr Qassid’s main areas of interest are education and training, digital pathology and the use of social media platforms to deliver teaching and assistance in challenging cases to pathologists worldwide.

He has also served as an RCPath Country Advisor for Iraq and has recently been appointed as the Royal College of Pathologist international associate regional advisor for the Middle East and North Africa.

Dr. Clara Limbaeck is a highly accomplished neuropathologist with a wealth of experience and expertise in her field. She received her Medical Degree in 1994 and went on to specialize in Histopathology, earning her Specialist Doctor in Histopathology qualification from the Medical Chamber of Slovenia in 2010. In 2016, she completed her PhD in Biochemistry and Molecular Biology from the University of Ljubljana, where her doctoral thesis focused on the role of nuclear calcium/calmodulin complex in long-term memory consolidation.

‍

Dr. Limbaeck's primary area of interest is neuropathology, with a focus on primary CNS tumors, molecular pathology, and inflammatory myopathies. She has published extensively in her field and has been a lead author in many important papers, including "Cerebrospinal fluid cytology findings in a case of diffuse leptomeningeal glioneuronal tumor," "2021 classification of tumors of the central nervous system: a review for the neuroradiologist," and "Characterization of IDH mutant WHO grade 2 and 3 gliomas: magnetic resonance imaging predictors of 1p/19q codeletion and tumor grade."

‍

Dr. Limbaeck has held several positions throughout her career, including as a Consultant Neuropathologist at the Department of Neuropathology at John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust in Oxford, UK, where she is currently employed. She has also served as the Specialty Lead for Neuropathology at North West London Pathology, Imperial College Healthcare NHS Trust in London, UK. Additionally, she has worked as an Honorary Senior Lecturer at the Division of Brain Sciences at Imperial College in London.

‍

Dr. Limbaeck has also been active in the research community throughout her career, serving as a Co-editor for Frontiers in Neurology and as a PhD Co-mentor for a postgraduate research student at the University of Portsmouth. She has also been a Principal Investigator for the Neuropathology Collection at the Imperial College Tissue Bank in London, UK.

‍

Throughout her career, Dr. Limbaeck has been committed to teaching and training in neuropathology. She has served as an Educational Supervisor in Histopathology for multiple trainees at Imperial College Healthcare NHS Trust, London, UK, and has lectured medical and graduate students in Neurosciences at the Faculty of Medicine, Imperial College, London, UK.

‍

In summary, Dr. Clara Limbaeck is a highly accomplished neuropathologist with a deep interest in primary CNS tumors, molecular pathology, and inflammatory myopathies. She has published extensively in her field, held multiple leadership and research positions, and has been committed to teaching and training the next generation of neuropathologists.

‍

He serves as the Medical Director at Eastern State Hospital, Medical Lake, Washington and Pathology Representative and Medical Director of Anatomic Pathology at Sacred Heart Medical Center, Spokane, Washington. Dr. Logani obtained his medical degree from Maulana Azad Medical College, Delhi University in New Delhi, India, and completed his pathology residency at Wayne State University in Detroit, MI. Following his residency, he completed a fellowship in cytopathology at the Hospital of the University of Pennsylvania and a gynecologic pathology fellowship at Weill Medical College of Cornell University in New York City, NY. 

He worked as a staff Gynecologic Pathologist at Emory University. 

Additionally, Dr Logani has written numerous papers in Gynecologic pathology and is internationally renowned in this sub-speciality.

He is also the pathology lead for Northern Ireland's Bowel Cancer Screening Programme. Dr. Loughrey is a member of the Colorectal Cancer Regional Group of the Northern Ireland Cancer Network (NICaN), as well as the UK Pathology Steering Group for Bowel Cancer Screening. Dr Loughrey is Vice-Chair of Council for the Northern Ireland Cancer Registry and Chair of the International Collaboration for Cancer Reporting (ICCR), Colorectal Cancer group.

He holds impressive qualifications including an MD, PhD, DMJ (Path), and FRCPath. Affiliated with King's College, Dr. Marnerides is recognized for his expertise in placenta pathology and autopsy pathology.

His significant contributions to the field are evident through numerous publications in esteemed journals such as J Med Case Rep, Front Endocrinol (Lausanne), and BMC Med Genomics. Dr. Marnerides's research spans various aspects of pathology, from the molecular mechanisms of disease to clinical outcomes.

With a commitment to advancing knowledge and understanding in pathology, Dr. Andreas Marnerides stands as a respected figure in both academic and medical communities.

He holds an MD and has extensive experience in academia, currently serving as a Pathologist at Southern Hills Medical Center, associated with PathGroup in Nashville, TN.

Dr. Marwaha completed his residency at St. Louis University Hospital and a Cytopathology fellowship at Baylor College of Medicine. His research interests revolve around Gynecologic Pathology. He has contributed significantly to the field with key publications on melanocytoma, mucosa-associated lymphoid tissue lymphoma, and molecular markers for glial cell tumors.

Dr. Marwaha has been part of establishing international standards in pathology, notably within the American Society of Cytopathology and the College of American Pathologists. He has presented extensively at numerous conferences and received multiple awards for his research contributions.

Dr. Mattoch grew up in southern California and received her Bachelor of Science degree in Microbiology from the University of California at San Diego, Revelle College of Science and Engineering. She earned her medical degree and was elected to the Alpha Omega Alpha Medical Honor Society at Boston University. Dr. Mattoch then completed her residency in Anatomic Pathology at Stanford University, followed by intensive fellowships in Surgical Pathology and Dermatopathology, also at Stanford University.

Following training, Dr. Mattoch served as an Adjunct Professor in the Departments of Pathology and Dermatology at Stanford while also serving as sole dermato pathologist at the California Skin Institute. Since 2010, Dr. Mattoch has served providers and patients throughout Northern Colorado and Nationwide with consultation level pathology services.

In addition to Dermatopathology, Dr. Mattoch’s subspecialty interests include but are not limited to Ophthalmic pathology, Gynecologic/genital pathology, Wound pathology, Oral pathology, Podiatric pathology, and Orthopedic pathology. She has published articles in the Journal of the American Academy of Dermatology (JAAD), among others. In her spare time, Dr. Mattoch enjoys skiing, cycling and cooking with her daughters.

Terence Moyana is a skilled pathologist based in Ottawa, Ontario, Canada. He holds an MD degree and is a Fellow of the Royal College of Physicians of Canada (FRCPC). Dr. Moyana specializes in Anatomic Pathology, with a sub-specialty focus on Gastrointestinal & Liver Pathology. His areas of interest within this specialty include colorectal cancer and neuroendocrine tumors.

‍

Dr. Moyana has contributed to several publications, with some of his notable work including articles on gallbladder cancer, pancreatic neuroendocrine tumors, and EGFR expression variance in colorectal cancer primary and metastatic tumors. These papers have been published in prestigious journals such as the Canadian Association of Radiologists Journal, the Journal of Pancreatic Cancer, and Cancer Biology & Therapy.

‍

In addition to his clinical practice, Dr. Moyana is an active member of the academic community, serving as a Professor in the Department of Pathology and Laboratory Medicine at the University of Ottawa.

‍

When he's not working, Dr. Moyana enjoys spending his leisure time on the tennis court, showcasing his skills as an avid tennis player.

‍

He is a recognized expert in his field with qualifications including a BSc (Hons), MBChB, and FRCPath. Dr. Moyes is an integral member of the local and regional Skin Cancer Multidisciplinary Team (MDT), providing expertise in diagnosing and managing skin tumors.

He actively contributes to the national Dermatopathology External Quality Assurance Scheme, ensuring diagnostic accuracy at a national level. As the National Lead for Advanced Practice and BMS Specimen Dissection, he demonstrates leadership in maintaining high standards of pathology services. Dr. Moyes has authored National Skin Cancer Guidelines, a Dermatopathology chapter in an undergraduate textbook, and numerous journal articles, showcasing his scholarly contributions. With previous leadership roles in NHS Boards, Dr. Moyes is a dedicated professional committed to advancing dermatopathology and pathology practice in the UK.

‍

Dr. Murugan has contributed over 75 peer-reviewed publications, numerous scientific meeting presentations, book chapters and has lectured nationally and internationally. He is an associate editor for the journal Diagnostic Pathology and member of the College of American Pathologists' Cancer Committee. He also serves as Medical Director of the University of Minnesota CTSI's Biorepository and Laboratory Services.

He is based in Manchester, UK and is a member of the USCAP, European Society of Pathology and International Society of Urological Pathology. Dr Soares de Oliveira is also an associate member of the Royal College of Pathologists (RCPath).

Following this, she completed a Surgical Pathology fellowship at Western University with a focus in Gastrointestinal Pathology (2016). After working one year as a General Anatomical Pathologist, she completed her fellowship in Dermatopathology at the University of Toronto, Toronto, ON Canada (2018).  She is a Dermatopathologist in the Department of Pathology and Laboratory Medicine in Saskatoon, SK. Dr. Osmond has a keen interest in digital pathology and teaching dermatopathology to residents, medical students in particular via the global #dermpath Twitter community @redsnapperpath.

Dr Pal has numerous publications focused on lung pathology and fellowship trained at Memorial Sloan Kettering, New York and Brigham and Women’s Hospital, Boston.

She is highly regarded in her field with a strong academic background, including a BSc (Hons), MBChB, and FRCPath. Dr. Paul brings extensive experience to her role as a specialist dermatopathologist at the Queen Elizabeth University Hospital in Glasgow, where she previously served as a specialty team lead. Actively engaged in dermatopathology, she is a core member of multiple skin cancer Multidisciplinary Teams (MDTs) and contributes to the tertiary referral service for skin biopsies. 

Dr. Paul's commitment to quality is demonstrated through her membership in the National Dermatopathology External Quality Assurance (EQA) Scheme. She has also made significant contributions to the field through numerous publications in peer-reviewed dermatopathology journals, solidifying her reputation as a leader in the field.

He is based in London, UK and has several publications in his area of expertise.

His areas of interest include; Human papillomavirus (HPV) and Head and neck squamous cell carcinoma (HNSCC), sinonasal tumor pathology. He has numerous peer reviewed publications with an H score of 60 and has an interest in the application of Artificial Intelligence and Deep Learning to Pathology.

With expertise in general surgical pathology and hematopathology, she is particularly interested in gastrointestinal (GI), skin and breast cancer diagnoses, and molecular testing within oncology and lymphoma. Dr. Pryor has dedicated 12 years to practicing general surgical pathology within community hospitals, demonstrating proficiency in diagnosing a wide spectrum of conditions.

While she hasn't been actively publishing during her practice, her focus on diverse areas of pathology reflects her commitment to providing comprehensive diagnostic services and expertise within the field of pathology.

Mara has a particular interest in melanocytic lesions and inflammatory skin conditions, excluding lymphoma. Her expertise is highlighted by several notable publications, including "Epitheliod Haemangioendothelioma Presenting in the Skin: A Clinicopathologic Study of Eight Cases" published in the American Journal of Dermatopathology, and "Deep Penetrating Naevus: Clinicopathological Study of 31 Cases" in Histopathology. She has also contributed to research on metastatic spread in ductal breast cancer and cutaneous infections. Dr. Quante's extensive research and clinical practice have significantly advanced the understanding and treatment of complex dermatopathological conditions. Her contributions to the field are widely recognized, making her a leading expert in diagnosing and studying skin-related diseases

Dr. Andrew R Bamber is a highly accomplished consultant in paediatric and perinatal pathology. He holds a Doctor of Medicine (Research) from University College London, a postgraduate diploma in forensic medicine and science (with distinction) from the University of Edinburgh, and a Bachelor of Medicine, Bachelor of Surgery from the University of Cambridge. Dr. Bamber has published extensively on topics such as sudden infant death and Kawasaki disease. He is currently a consultant paediatric and perinatal pathologist at North Bristol NHS Trust and an honorary consultant paediatric pathologist at Cardiff and Vale University Health Board. He has received prestigious awards, including the Pediatric Pathology Society Normal Brown Award and the Lucas Medal in Forensic Medicine from the University of Edinburgh. Dr. Bamber is actively involved in esteemed societies and associations, including the British Association in Forensic Medicine and the Children's Cancer and Leukaemia Group.

‍

He was appointed as a Consultant Cardiothoracic and Transplant Pathologist at The Royal Brompton and Harefield Clinical Group as part of the Guy’s and St Thomas’ NHS Foundation Trust in February 2015. Besides his specialist interest in lung and cardiac pathology, he is also an Associate Clinical Chief Information Officer and Medical Information Officer at Guy’s and St Thomas’ NHS Foundation Trust. At The Royal Brompton and Harefield Clinical Group he is clinical lead for computational pathology.

He is an Honorary Senior Clinical Lecturer at the Faculty of Medicine, National Heart and Lung Institute, Imperial College London and visiting Professor at the University of Antwerp. His main research interests are Artificial Intelligence, computational pathology, specifically in the areas of lung pathology and specifically thoracic oncology, cardiovascular disease, cardiac and pulmonary transplantation.

She holds an MD degree from Tehran University of Medical Sciences, Iran, and has undergone extensive postgraduate training and specialization in the field of Anatomical Pathology. Dr. Rouzbahman is a Fellow of Anatomical Pathology at the Royal College of Physicians and Surgeons of Canada. She is also licensed by the Medical Council of Canada and the College of Physicians and Surgeons of Ontario.

Currently, Dr. Rouzbahman holds key positions at the University Health Network and Toronto General Hospital in Toronto, Ontario, Canada. She serves as a Staff Pathologist in the Division of Anatomical Pathology at the University Health Network, where she has been actively involved in the clinical practice of gynecological pathology. She is also an Associate Professor in the Division of Anatomical Pathology at the Department of Laboratory Medicine and Pathobiology, University of Toronto. Dr. Rouzbahman has made significant contributions to the field of gynecologic oncology through her research, teaching, and clinical practice.

Her primary focus is on studying rare and unusual malignant neoplasms of the female genital tract, with the aim of developing diagnostic criteria and identifying biomarkers to aid in the diagnosis and management of these rare tumors. She is particularly interested in biomarkers in gynecologic pathology, which include specific proteins, genetic markers, or molecular signatures that provide valuable information for personalized treatment planning and monitoring the response to therapy.

Dr. Rouzbahman has been actively involved in various research projects related to gynecologic pathology, including Her2-Neu testing in uterine serous carcinoma, and the exploration and validation of Her2-Neu in ovarian mucinous adenocarcinoma. She has also focused on malignant mesenchymal neoplasms of the uterus, such as leiomyosarcoma, endometrial stromal sarcoma, adenosarcoma, and other rare entities. Her work has led to several publications, citations, lectures, and workshops, contributing to the advancement of gynecologic pathology.

In summary, Dr. Marjan Rouzbahman is a dedicated pathologist and researcher with a strong commitment to advancing the understanding and diagnosis of gynecologic malignancies. Her work in biomarker analysis and the classification of rare gynecological tumors has made her a valuable contributor to the field, both in Canada and internationally.

With a focus on Hematopathology, he has a keen interest in Hodgkin and non-Hodgkin Lymphomas, Myelodysplastic Syndrome (MDS), and Histiocytic neoplasms. Dr. Sakhdari's expertise and dedication are evident through his contributions to the field, with a notable portfolio of publications reflecting his research interests.

Affiliated with the prestigious University Health Network and the University of Toronto, Dr. Sakhdari plays a crucial role in advancing education, research, and patient care within the academic community. His commitment to excellence in pathology, combined with his academic affiliations, positions Dr. Ali Sakhdari as a respected figure in the field, shaping the future of pathology in Canada and beyond.

Dr. Saxena received her medical qualifications from Bombay University, India, including an MBBS and MD in Pathology, before achieving further accreditation as a Fellow of the Royal College of Pathologists (FRCPath) in the UK.

She has established herself as a notable authority in liver pathology and has contributed significantly to the field through her academic and clinical roles. Dr. Saxena serves as the Director of the Liver Pathology Service and the Medical Director of the Histology Laboratory at Emory University School of Medicine. Her role also includes directing the Gastrointestinal and Liver Pathology Fellowship.

Throughout her illustrious career, she has been deeply involved in research, particularly in liver pathophysiology, liver diseases, and hepatic neoplasms. Dr. Saxena has a remarkable record of publications in esteemed journals such as the American Journal of Surgical Pathology, Journal of Clinical Oncology, Seminars in Diagnostic Pathology, and Virchows Archiv, among others. Her research has delved into various aspects of liver diseases, diagnostic approaches, and therapeutic interventions, encompassing a broad spectrum of topics from primary liver tumors to drug-induced liver injury and hepatic fibrosis.

Dr. Saxena has played a pivotal role in shaping international standards in pathology, serving as an editorial board member for prestigious journals like Pathology and Modern Pathology. She has also been an active participant in various committees and professional societies, including the American Association for the Study of Liver Diseases and the United States and Canadian Association of Pathologists, where she contributes as a reviewer and mentor.

Her extensive academic journey spans across multiple continents, with academic appointments at distinguished institutions including King's College Hospital in London, Mount Sinai School of Medicine in New York, and Indiana University School of Medicine, among others. Dr. Saxena has been an invited lecturer at numerous conferences and has directed several teaching courses on liver pathology, demonstrating her commitment to education and mentorship in the field.

Dr. Romil Saxena's enduring dedication to liver pathology, extensive research contributions, commitment to education, and leadership in the field have established her as a revered figure in the realm of pathology and liver sciences.

Specializing in Histopathology, her sub-specialties include Gastrointestinal Pathology, Head and Neck Pathology, Hepatopathology, and non-gynae cytology.

Dr. Sleigh's primary interest lies in colorectal cancer, and she has made significant contributions to the field through her research and publications. Notable works include "Multicentre Investigation of Prognostic Factors for Anal Cancer after Chemoradiotherapy" published in Clinical Oncology.

Affiliated with University Hospitals Sussex, Dr. Sleigh also serves as an educational supervisor within the KSS deanery, demonstrating her commitment to training the next generation of pathologists. With her expertise and dedication to advancing knowledge in histopathology, Dr. Kerry Sleigh is a respected figure in the medical community.

Anuj is board-certified in AP/CP and is the Chairman of the Quest Diagnostics/AmeriPath GI and Liver Resource Committee. Dr.Sonawala's professional interests are centered on Inflammatory Bowel Disease (IBD) in both pediatric and adult populations, Barrett’s esophagus and progression to dysplasia, and Eosinophilic Esophagitis. He is also keenly involved in the application of Artificial Intelligence in IBD, particularly developing AI algorithms associated with IBD.

He has contributed to the field with his publication, "A Comparative Immunohistochemical Analysis of Small Round Cell Tumors of Childhood: Utility of Peripherin and Alpha-Internexin as Markers for Neuroblastomas," which showcases his dedication to advancing medical knowledge. Dr. Sonawala's commitment to pathology and his leadership in the GI and Liver Resource Committee underscore his role as a key expert in his field.

With a specialized focus on gastrointestinal (GI) pathology and breast pathology, Dr. Sreehari has extensive expertise in diagnosing cancers and inflammatory disorders of the GI tract, as well as cancers and benign breast diseases. Her dedication to histopathology is reflected in her meticulous approach to understanding and diagnosing complex conditions, contributing significantly to patient care.

Dr. Sreehari has several publications showcasing her research and findings. Outside of her professional life, Dr. Sreehari enjoys traveling and reading, which enrich her understanding of diverse cultures and perspectives. Her passion for her field, combined with her hobbies, makes her a well-rounded and dedicated pathologist committed to advancing medical science and improving patient outcomes.

After completing her medical degree, Dr. Stueck underwent Anatomical Pathology residency at Dalhousie University, becoming a fellow of the Royal College of Physicians and Surgeons of Canada, then subsequently a specialized Liver Pathology Fellowship at Icahn School of Medicine at Mount Sinai. Presently, she holds the position of Associate Professor at Dalhousie University and works as an Anatomical Pathologist specializing in Hepatobiliary and Gastrointestinal Pathology at Nova Scotia Health Authority.

Dr. Stueck is an active member of numerous professional associations and societies such as the International Liver Pathology Study Group (ELVES), Laennec Liver Pathology Society, Hans Popper Hepatopathology Society, and USCAP, among others. Her engagement in these organizations signifies her commitment to ongoing learning and collaboration.

Her research focus primarily lies in liver pathology, including regeneration, neoplasia, autoimmune disease, and hepatic graft-versus-host disease. Dr. Stueck has presented extensively at international, national, and regional conferences. She has authored various peer-reviewed publications, editorials, and reviews in prominent journals.

Outside her professional duties, Dr. Stueck actively engages in community service, including volunteer work, student mentorship, and organizing conferences. Her involvement reflects her dedication to both academic pursuits and community initiatives.

Dr. Ashley Stueck's commitment to liver pathology, her extensive contributions to research and academia, and her active involvement in professional associations underscore her impact and dedication in the field of Anatomical Pathology.

With a diverse educational background spanning multiple countries and prestigious institutions, Dr. Sur has consistently demonstrated a commitment to excellence in her academic and professional pursuits.

Dr. Monalisa Sur holds multiple fellowships and qualifications from renowned institutions, including the Royal College of Pathologists in the U.K., the Royal College of Physicians and Surgeons of Canada, and the Colleges of Medicine of South Africa, among others. Her specializations in anatomical pathology and clinical pathology have provided her with a comprehensive understanding of disease processes and diagnostic techniques.

Over the years, Dr. Sur has actively engaged in continuous professional development, staying at the forefront of advancements in the field. Her participation in numerous conferences, workshops, and specialized training programs across the world highlights her dedication to ongoing learning and innovation. Notably, she has attended conferences such as the United States and Canadian Academy of Pathology (USCAP) and participated in various leadership development programs.

Dr. Sur currently holds the position of Professor with Continuous Appointment Without Annual Review (CAWAR) at McMaster University, Hamilton, Ontario, Canada. She is a staff pathologist at Hamilton Health Sciences Corporation, serving at Juravinski Hospital and Cancer Center, Hamilton General Hospital, and St. Joseph’s Health Care. Her role extends to academic leadership in the Department of Pathology and Molecular Medicine, reflecting her commitment to education and research.

In addition to her professional roles, Dr. Sur maintains active medical licenses with the College of Physicians and Surgeons of Ontario, Health Professionals Council of South Africa, and the Punjab Medical Council, underscoring her commitment to medical practice and patient care.

Dr. Monalisa Sur's professional affiliations include membership in several esteemed organizations, such as the Canadian Association of Pathologists (CAP-ACP), United States-Canadian Academy of Pathology (USCAP), and the American Society of Clinical Pathology (ASCP). Her involvement in these organizations reflects her dedication to networking, knowledge sharing, and collaboration within the medical community.

Recognized for her outstanding contributions and expertise, Dr. Sur has received numerous awards and honors throughout her career. Notably, she was honored with the Distinguished Service Award from the Canadian Association of Pathologists (CAP-ACP) in 2022. Her recognition extends to teaching and research, as she received the Resident-Nominated Clinical Faculty Award for Excellence in Teaching in 2022.

Dr. Monalisa Sur's commitment to the medical field, her extensive qualifications, and her dedication to ongoing learning make her a respected and influential figure in the field of pathology. Her work serves as an inspiration to aspiring pathologists and underscores her significance in advancing healthcare and patient outcomes.

Specialising in Histopathology, Dr. Swamy's sub-specialities encompass GI, Urology and Skin pathology.

His research interests primarily lie in colorectal, urology, and skin pathology, with notable contributions to the field. Dr Swamy has authored impactful publications such as "The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new hematuria patients—First European Data" in BJUI Compass and "Histopathological reporting of pT4 tumour stage in colorectal carcinomas: dotting the ‘i’s and crossing the ‘t’s" in J Clin Pathol.

With a dedication to advancing diagnostic accuracy and patient care, Dr. Rajiv Swamy continues to make significant contributions to histopathology.

She currently works as a Substantive Consultant at Queen Elizabeth University Hospital under NHS Greater Glasgow & Clyde. Dr. Syed's particpates in a number of external quality assurance schemes, including the British Association of Gynaecological Pathology EQA, NHS BPS (Breast Pathology EQA), and cervical cytology NHS Scotland EQA. Throughout her career, she has been deeply committed to teaching undergraduates, postgraduates, and biomedical scientists. Her notable publications in leading medical journals have significantly advanced the understanding of gynaecological and breast pathology. Dr. Sheeba Syed's dedication to her field and academic contributions have earned her recognition as a respected expert in the medical community.

He received his undergraduate A.B. degree from Harvard College, M.D. from Yale University School of Medicine, Anatomic and Clinical Pathology training at Yale-New Haven Hospital and New England Deaconess Hospital, and Dermatopathology specialty training at Massachusetts General Hospital.

In addition to active responsibilities in diagnostic Dermatopathology and Surgical Pathology, Dr. Tahan has been an active participant in national and international Pathology educational courses, workshops, and seminars. He also oversees an active research program in human cutaneous oncology.

American Board of Pathology Certified in Anatomic and Clinical Pathology.

American Board of Pathology Certified in Dermatopathology.

With a comprehensive academic background, including a Fellowship in Gastrointestinal Pathology at Brigham & Women’s Hospital and a Master’s Degree in Pathology from Kasturba Medical College, Taher has accrued significant experience and leadership in pathology. He served as Regional Clinical Chief of Anatomical Pathology at Eastern Health, directing provincial telepathology programs and contributing to various committees in advancing pathology standards.

Taher's contributions span internationally recognized publications in esteemed journals, involving topics like HER2 overexpression in gastric cancer and reporting guidelines for colorectal polyps. Having held academic roles and led residency training programs, his career embodies dedication to pathology education, clinical expertise, and the pursuit of advancing the understanding and treatment of gastrointestinal disorders.

Dr Sami Titi is a renowned Consultant Histopathologist and Clinical Director for Cellular Pathology at the Northern Care Alliance (NCA), based in Manchester, UK. With over 19 years of experience, Dr Titi is an expert in the field of histopathology, specializing in breast and uropathology. He is currently leading a team of 30 pathologists at the NCA, who are providing a comprehensive Cellular Pathology service to the trusts they serve. Dr Titi acts as a lead pathologist for breast multidisciplinary teams. In addition to his clinical responsibilities, Dr Titi has been involved in several research projects, including his PhD research on HER-2 gene amplification and protein p185 overexpression in invasive breast cancer. 

‍

He has contributed to a vast range of research papers, focusing on various aspects of oncology, pathology, parasitic diseases, and transgender health. His work includes case reports, analyses of diagnostic methods, and exploration of specific pathological conditions. Some of his most notable works include his research on the Human Epidermal growth factor Receptor 2 (HER2) test, primary fibrosarcoma of the thyroid gland, and a variety of case reports detailing rare pathological conditions.

‍

In addition to his numerous publications, Dr. Titi has made significant contributions to the Polish National Colorectal Screening Program. His work was acknowledged in the original publication by Jaroslaw Regula and colleagues titled "Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced Neoplasia" published in The New England Journal of Medicine in 2006. This research has played a crucial role in enhancing the effectiveness of colorectal cancer screening in Poland.

‍

Dr. Titi's contributions to text correction, a rare case of intestinal schistosomiasis, and microphotography of HER2 Fluorescence In Situ Hybridization (FISH) & Immunohistochemistry (IHC) were also acknowledged in a Polish pathology book titled "Patologia znaczy słowo o chorobie" by J. Stachura and W. Domagała, published in 2005.

‍

Dr Titi is a Fellow of The Royal College of Pathologists, a Fellow of the Polish Society of Pathology, and has completed several national and international courses, including many on medical leadership, which have helped him to continue delivering high-quality, consultant-led services. He has also organized and chaired several regional conferences on breast pathology and has been a clinical governance lead for cellular pathology.

‍

Throughout his career, Dr. Titi has demonstrated an unwavering commitment to advancing the fields of pathology and oncology, with his work having significant impacts on both research and clinical practice.

‍

His areas of interest include; Gastric and colonic cancers. Dr Vajpeyi has completed his Postgraduate Training at the University of Toronto. He has numerous publications in peer-reviewed literature.

He has over 500 peer-reviewed publications and a H-score of 111. Dr Van der Kwast is a past president of the international society of pathologists with interest in urological pathology.

Her areas of interest include; familial gastrointestinal cancers, Neuroendocrine neoplasms, anal pathology. Dr. Vyas has numerous publications in peer-reviewed literature.

She has extensive diagnostic and research experience in Gynaecological Cancers, with a particular interest in ovarian and endometrial cancers.

She is a member of a number of related professional bodies, including the BAGP, ISGyP and USCAP. During her career she has published and presented in the fields of Gynaecological Pathology and cytopathology nationally and internationally. She has well established links and several ongoing collaborations with colleagues in the Ukrainian medical education post-graduate centre in Kyiv and is currently the Royal College of Pathologists Advisor for Ukraine.

Based in Chapel Hill, North Carolina, she is an esteemed faculty member at the University of North Carolina (UNC) at Chapel Hill. D

r. Wobker's expertise encompasses diseases affecting the kidneys, bladder/urinary tract, testis, and prostate. Her influential research, highlighted in notable publications such as studies on prostate cancer metastases, molecularly defined renal carcinomas, and metastatic solid tumors, demonstrates her commitment to advancing diagnostic methods in genitourinary pathology.

Her contributions significantly shape the understanding of diseases within the urinary system and male reproductive organs, establishing her as a pivotal figure in this specialized field of pathology.

She is based in Toronto and has numerous peer reviewed publications.